Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors

被引:31
|
作者
Ungerback, Jonas [1 ]
Ahsberg, Josefine [1 ]
Strid, Tobias [1 ]
Somasundaram, Rajesh [1 ]
Sigvardsson, Mikael [1 ]
机构
[1] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Expt Hematopoiesis Unit, S-58183 Linkoping, Sweden
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2015年 / 212卷 / 07期
基金
瑞典研究理事会;
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR EBF; LYMPHOID PROGENITORS; TARGET GENES; IN-VITRO; DIFFERENTIATION; NOTCH1; COMMITMENT; SPECIFICATION; FATE;
D O I
10.1084/jem.20132100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate how transcription factor levels impact B-lymphocyte development, we generated mice carrying transheterozygous mutations in the Pax5 and Ebf1 genes. Whereas combined reduction of Pax5 and Ebf1 had minimal impact on the development of the earliest CD19(+) progenitors, these cells displayed an increased T cell potential in vivo and in vitro. The alteration in lineage fate depended on a Notch1-mediated conversion process, whereas no signs of de-differentiation could be detected. The differences in functional response to Notch signaling in Wt and Pax5(+/-) Ebf1(+/-) pro-B cells were reflected in the transcriptional response. Both genotypes responded by the generation of intracellular Notch1 and activation of a set of target genes, but only the Pax5(+/-) Ebf1(+/-) pro-B cells down-regulated genes central for the preservation of stable B cell identity. This report stresses the importance of the levels of transcription factor expression during lymphocyte development, and suggests that Pax5 and Ebf1 collaborate to modulate the transcriptional response to Notch signaling. This provides an insight on how transcription factors like Ebf1 and Pax5 preserve cellular identity during differentiation.
引用
收藏
页码:1109 / 1123
页数:15
相关论文
共 50 条
  • [1] HAPLOINSUFFICIENCY OF TRANSCRIPTION FACTORS EBF1 AND PAX5 IN PRO-B CELL LEUKEMIA
    Kometani, Kohei
    Ramamoorthy, Senthilkumar
    Boller, Soeren
    Grosschedl, Rudolf
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S89 - S89
  • [2] EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms
    Li, Li
    Zhang, Daiquan
    Cao, Xinmei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene
    Somasundaram, Rajesh
    Jensen, Christina T.
    Tingvall-Gustafsson, Johanna
    Ahsberg, Josefine
    Okuyama, Kazuki
    Prasad, Mahadesh
    Hagman, James R.
    Wang, Xun
    Soneji, Shamit
    Strid, Tobias
    Ungerback, Jonas
    Sigvardsson, Mikael
    BLOOD, 2021, 137 (22) : 3037 - 3049
  • [4] Temporal and Sequential Expression of EBF1 and PAX5 Restricts the Non-B Cell Fate In Early Lymphopoiesis
    Zandi, Sasan
    Zetterblad, Jenny
    Tsapogas, Panagiotis
    Mansson, Robert
    Sigvardsson, Mikael
    BLOOD, 2010, 116 (21) : 1581 - 1581
  • [5] Myc represses Ebf1 and Pax5 to impair early B-cell differentiation and drive progenitor B lymphomagenesis
    Schaub, Franz X.
    Yang, Chunying
    Li, Weimin
    Hall, Mark A.
    Peppers, Lottie
    Fallahi, Mohammad
    Doherty, Joanne R.
    Cleveland, John L.
    CANCER RESEARCH, 2011, 71
  • [6] EBF1–JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity
    Yukino Kojima
    Fumika Kawashima
    Takahiko Yasuda
    Koya Odaira
    Yuichiro Inagaki
    Chiharu Yamada
    Ami Muraki
    Mina Noura
    Shuichi Okamoto
    Shogo Tamura
    Eisuke Iwamoto
    Masashi Sanada
    Itaru Matsumura
    Yasushi Miyazaki
    Tetsuhito Kojima
    Hitoshi Kiyoi
    Shinobu Tsuzuki
    Fumihiko Hayakawa
    International Journal of Hematology, 2023, 118 : 65 - 74
  • [7] Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis
    Li, Jinpeng
    Bhattacharya, Sudin
    Zhou, Jiajun
    Phadnis-Moghe, Ashwini S.
    Crawford, Robert B.
    Kaminski, Norbert E.
    JOURNAL OF IMMUNOLOGY, 2017, 199 (10): : 3504 - 3515
  • [8] EBF restricts alternate lineage options and promotes B cell fate commitment independently of Pax5
    Lancki, David William
    Pongubala, Jagan M. R.
    Northrup, Daniel L.
    Medina, Kay L.
    Treiber, Thomas
    Bertolino, Eric
    Thomas, Matthew
    Grosschedl, Rudolf
    Allman, David
    Singh, Harinder
    FASEB JOURNAL, 2008, 22
  • [9] Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia
    Heltemes-Harris, Lynn M.
    Willette, Mark J. L.
    Ramsey, Laura B.
    Qiu, Yi Hua
    Neeley, E. Shannon
    Zhang, Nianxiang
    Thomas, Deborah A.
    Koeuth, Thearith
    Baechler, Emily C.
    Kornblau, Steven M.
    Farrar, Michael A.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (06): : 1135 - 1149
  • [10] Distinct promoters mediate the regulation of Ebf1 gene expression by interleukin-7 and Pax5
    Roessler, Stephanie
    Gyoery, Ildiko
    Imhof, Sascha
    Spivakov, Mikhail
    Williams, Ruth R.
    Busslinger, Meinrad
    Fisher, Amanda G.
    Grosschedl, Rudolf
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (02) : 579 - 594